Hypolipidemia.
Clinically significant hypolipidemia, although less common than hyperlipidemia, usually has important consequences that involve derangement of one or more of the major roles of lipoproteins. Deficiencies of lipoproteins are discussed under their classification as genetic disorders or as the presenting features of underlying disease.
D000012:Abetalipoproteinemia / Q000150:complications / Q000378:metabolism / Q000628:therapy; D002914:Chylomicrons / Q000378:metabolism; D006801:Humans; D006995:Hypobetalipoproteinemias / Q000378:metabolism; D007009:Hypolipoproteinemias / Q000209:etiology / Q000378:metabolism*; D007136:Immunoglobulins / Q000378:metabolism; D007863:Lecithin Cholesterol Acyltransferase Deficiency / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D008107:Liver Diseases / Q000150:complications; D009748:Nutrition Disorders / Q000150:complications; D013631:Tangier Disease / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D007136:Immunoglobulins; D008074:Lipoproteins; D014280:Triglycerides